Melissa Sherman went from a MOBILion investor to its CEO. She has lead the still-young company that's focused on developing lab instruments that improve the prediction, diagnosis and treatment of disease through more than $100 million in fundraising to propel it to its next phase. She talks about her transition into the business, what she's learned being on the other side of the fundraising table, and how her experience leading two companies at different lifecycle stages to an exit has informed the way she's building MOBILion.
Smart Business Dealmakers: The Middle-Market M&A Podcast